News

MacuLogix, a pioneer in the early detection and tracking of age-related macular degeneration (AMD), tapped Zer0 to 5ive to help develop its website, generate awareness among key stakeholders, and lay the groundwork for FDA clearance of its products. To support this effort, Zer0 to 5ive has successfully launched a new website, which reflects the new messaging and positioning the team developed with MacuLogix and is built to scale with the company and its ongoing marketing initiatives.